| Literature DB >> 19893698 |
A S Pradhan1, J I Lee, J L Kim.
Abstract
During the last 10 years, optically stimulated luminescence (OSL) has emerged as a formidable competitor not only to thermoluminescence dosimetry (TLD) but also to several other dosimetry systems. Though a large number of materials have been synthesized and studied for OSL, Al(2)O(3):C continues to dominate the dosimetric applications. Re-investigations of OSL in BeOindicate that this material might provide an alternative to Al(2)O(3):C. Study of OSL of electronic components of mobile phones and ID cards appears to have opened up a feasibility of dosimetry and dose reconstruction using the electronic components of gadgets of everyday use in the events of unforeseen situations of radiological accidents, including the event of a dirty bomb by terrorist groups. Among the newly reported materials, a very recent development of NaMgF(3):Eu(2+) appears fascinating because of its high OSL sensitivity and tolerable tissue equivalence. In clinical dosimetry, an OSL as a passive dosimeter could do all that TLD can do, much faster with a better or at least the same efficiency; and in addition, it provides a possibility of repeated readout unlike TLD, in which all the dose information is lost in a single readout. Of late, OSL has also emerged as a practical real-time dosimeter for in vivo measurements in radiation therapy (for both external beams and brachytherapy) and in various diagnostic radiological examinations including mammography and CT dosimetry. For in vivo measurements, a probe of Al(2)O(3):C of size of a fraction of a millimeter provides the information on both the dose rate and the total dose from the readout of radioluminescence and OSL signals respectively, from the same probe. The availability of OSL dosimeters in various sizes and shapes and their performance characteristics as compared to established dosimeters such as plastic scintillation dosimeters, diode detectors, MOSFET detectors, radiochromic films, etc., shows that OSL may soon become the first choice for point dose measurements in clinical applications. A brief review of the recent developments is presented.Entities:
Keywords: Accident/space/clinical dosimetry; dosimeters; optically stimulated luminescence; real-time on-line measurements
Year: 2008 PMID: 19893698 PMCID: PMC2772040 DOI: 10.4103/0971-6203.42748
Source DB: PubMed Journal: J Med Phys ISSN: 0971-6203
Figure 1Simple representation of electron and hole ion pair production by ionizing radiation, movement (using arrows similar to those followed in books[14]), trapping, re-trapping, transfer between the traps, recombination, and luminescence emission. (A) Shows a simple case of TL or OSL with no intertransfer of the charge carrier among the traps. (B) Shows the delayed emission (DOSL) through photo-transfer via shallow traps (used in optically enhanced phosphorescence) and also if the luminescence center has higher lifetime (used in POSL, which is the other type of DOSL). (C) Shows the modes of photo-transferred optically stimulated luminescence (PTOS), photo-transferred thermoluminescence (PTTL), and cooled optically stimulated luminescence (COSL). 1- electron trap, 2- hole trap or recombination center associated with a luminescent center, 3- shallow trap, and 4- deep trap responsible for photo-transfer. For details, see text
Figure 2Representation of different modes of optically stimulated luminescence and its decay with time. Stimulation starts at time t1 and ends at t2 (for details, see text). For DOSL, the time scale in minutes is for optically enhanced phosphorescence through photo-transfer
OSL efficiency of Al2O3:C Luxel™ type and single-crystal dosimeter to high energy heavy charged particles relative to gamma rays for the readouts in three modes: 1. the initial CW-OSL (integrated for the first 3 seconds), 2. integrated CW-OSL readout (integrated for 300 seconds), and 3. POSL readout[1631]
| H | 0.22 | 0.98 – | 0.91 – | – |
| H | 0.413 | 1.11 – | 0.95 – | – |
| H | 0.96 | 1.10 – | 0.93 – | – |
| He | 2.26 | 1.37 1.01 | 1.00 0.83 | 0.81 |
| C | 11.20 | 1.32 0.73 | 0.76 0.53 | 0.60 |
| Si | 55.70 | 0.85 0.42 | 0.47 0.33 | 0.38 |
| Fe | 193.00 | 0.64 0.38 | 0.38 0.30 | 0.31 |
Main characteristics of some optically stimulated luminescence materials
| AI203:C[ | 1.00 | μGy-10Gy | 450-550 | ∼420 | <5%/y | 11.3 |
| BeO[ | ∼1.00 | μGy-10Gy | ∼ 435 | ∼335 | 6% in 1st 10 h and then nil | 7.2 |
| MgO:Tb[ | ∼1.00 | 100μGy- 10Gy | 500-560 | 375, 420, 440, 470, 500, 650 | 43% in 1st 36 h and then nil | 10.8 |
| NaMgF3:Eu[ | ∼10.0 | μGy -100Gy | ∼ 470 | 360 | 40% in 1st 24 h and then nil | 10.4 |
| KMgF3:Cei[ | ∼10.0 | 1μGy- 10Gy | ∼ 470 | ∼360 | High and 40K Self-irradiation. | 14.7 |
| Li2AI204:Tb[ | ∼0.01 | 200μGy- 10Gy | <532 | 370, 420 and 440 | 50% in 1st 50 h | 9.74 |
| Mg2SiO4:Tbi[ | ∼0.11 | 30μGy- 10Gy | <532 | 370, 420 and 440 | 30% in 1st 10 h and then 0 | 11.23 |
| Mg2SiO4:Tb,Co[ | ∼0.08 | 40μGy- 10Gy | <532 | 370, 420 and 440 | 30% in 1st 10 h and then nil | 11.23 |
| KCI:Eu[ | ∼1.00 | 100μGy- 10Gy | 500-560 | 350-480 and 560-700 | High and 40K Self-irradiation | 18.1 |
| KBr:Eu[ | ∼1.00 | 100μGy- 10Gy | 500-560 | 350-480 and 560-700 | High and 40K | 31.76 |
| (NH4)2SiF6:TI[ | ∼0.02 | > few mGy | 470 | 300-370 | Self-irradiation 80% in 1st 10 h | 10.31 |
| Y3AI5O12:C[ | ∼0.10 | 10mGy- 100Gy | 500-560 | 350-480 and 560-700 | Negligible in 2 months | 33.81 |
Energy dependence of Al2O3:C (0.3 mm thick and 7 mm diameter, wrapped in black tape of thickness 34 mg/cm2) to photon (at dmax) and electron radiotherapy beams from Varian 21 EX linear accelerator[65]
| 6 MV Photon | 1.000 | 1.000 |
| 18 MV Photon | 1.005 | 1.005 |
| 9 MeV Electron | 1.019 | 1.000 |
| 20 MeV Electron | 1.023 | 1.003 |
Figure 3A simple schematic representation of real-time/on-line readout system and the recording of RL and OSL signals